化合物Compound 35 T8686
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | T8686 | ¥7,500.00 | 询底价 |
10 mg | T8686 | ¥2,590.00 | 询底价 |
500 mg | T8686 | ¥15,100.00 | 询底价 |
25 mg | T8686 | ¥4,130.00 | 询底价 |
50 mg | T8686 | ¥5,590.00 | 询底价 |
2 mg | T8686 | ¥1,170.00 | 询底价 |
5 mg | T8686 | ¥1,750.00 | 询底价 |
1 mg | T8686 | ¥774.00 | 询底价 |
Product Introduction
Bioactivity
英文名: VUN65671
描述: Compound 35 是埃博拉 (Mayinga) 和马尔堡 (安哥拉) 传染性病毒的优良抑制剂。
体外活性: Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses. Compounds 35 have shown good metabolic stability in plasma and liver microsomes (rat and human), and 32 did not inhibit CYP3A4 nor CYP2C9. These 4-(aminomethyl)benzamides are suitable for further optimization as inhibitors of filovirus entry, with potential to be developed as therapeutic agents for the treatment and control of Ebola virus infections.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 6.00mg/ml
关键字: VUN 65671 | VUN-65671 | Compound 35 | VUN65671
相关库: Bioactive Compounds Library Max | Inhibitor Library | Anti-Viral Compound Library | Bioactive Compound Library | Anti-Infection Compound Library
化合物Compound 35 T8686信息由TargetMol中国为您提供,如您想了解更多关于化合物Compound 35 T8686报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途